Karola Beckmann
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Journal: Journal of neurology
Published: July 15, 2015
Effects of inhibitors of the renin-angiotensin system on the efficacy of interferon beta-1b: a post hoc analysis of the BEYOND study.
Journal: European neurology
Published: April 10, 2013
VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study.
Journal: The British journal of ophthalmology
Published: January 10, 2013
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study.
Journal: Journal of neurology
Published: December 19, 2012
Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.
Journal: Neurology
Published: April 13, 2012
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: December 24, 2011
Cost-effectiveness analysis of interferon beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosis.
Journal: Clinical therapeutics
Published: November 25, 2011
Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 29, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026